DK1574572T3 - Forbindelser til hydrolyse af ribonukleinsyrer (RNA'er) - Google Patents

Forbindelser til hydrolyse af ribonukleinsyrer (RNA'er)

Info

Publication number
DK1574572T3
DK1574572T3 DK04075764T DK04075764T DK1574572T3 DK 1574572 T3 DK1574572 T3 DK 1574572T3 DK 04075764 T DK04075764 T DK 04075764T DK 04075764 T DK04075764 T DK 04075764T DK 1574572 T3 DK1574572 T3 DK 1574572T3
Authority
DK
Denmark
Prior art keywords
compounds
rnas
hydrolysis
ribonucleic acids
relates
Prior art date
Application number
DK04075764T
Other languages
Danish (da)
English (en)
Inventor
Brigitte Wanner
Gerard Platenburg
Original Assignee
Prosensa Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prosensa Bv filed Critical Prosensa Bv
Application granted granted Critical
Publication of DK1574572T3 publication Critical patent/DK1574572T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
    • C12N2310/3181—Peptide nucleic acid, PNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3511—Conjugate intercalating or cleaving agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/30—Production chemically synthesised

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
DK04075764T 2004-03-09 2004-03-09 Forbindelser til hydrolyse af ribonukleinsyrer (RNA'er) DK1574572T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04075764A EP1574572B1 (de) 2004-03-09 2004-03-09 Verbindungen zur Hydrolyse von Ribonukleinsäuren (RNS)

Publications (1)

Publication Number Publication Date
DK1574572T3 true DK1574572T3 (da) 2007-09-24

Family

ID=34814336

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04075764T DK1574572T3 (da) 2004-03-09 2004-03-09 Forbindelser til hydrolyse af ribonukleinsyrer (RNA'er)

Country Status (12)

Country Link
US (1) US20090233981A1 (de)
EP (1) EP1574572B1 (de)
JP (1) JP2007528224A (de)
CN (1) CN100537763C (de)
AT (1) ATE362981T1 (de)
AU (1) AU2005219815B2 (de)
CA (1) CA2559114A1 (de)
DE (1) DE602004006599T2 (de)
DK (1) DK1574572T3 (de)
ES (1) ES2287634T3 (de)
PL (1) PL1574572T3 (de)
WO (1) WO2005085442A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2308514B1 (de) 2007-03-23 2013-06-05 to-BBB Holding B.V. Konjugate zum Arzneimitteltransport über die Blut-Hirn-Schranke
JP5429039B2 (ja) * 2010-05-17 2014-02-26 株式会社島津製作所 酸加水分解によるｒｎａの分解方法及びそれを用いたｒｎａの配列解析方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07255483A (ja) * 1994-03-22 1995-10-09 Makoto Komiyama リボ核酸を切断する方法
JP3658697B2 (ja) * 1997-01-14 2005-06-08 独立行政法人科学技術振興機構 人工リボヌクレアーゼ及びその製造法

Also Published As

Publication number Publication date
CN100537763C (zh) 2009-09-09
CN1946845A (zh) 2007-04-11
WO2005085442A2 (en) 2005-09-15
DE602004006599D1 (de) 2007-07-05
WO2005085442A3 (en) 2006-01-05
JP2007528224A (ja) 2007-10-11
ATE362981T1 (de) 2007-06-15
EP1574572A1 (de) 2005-09-14
EP1574572B1 (de) 2007-05-23
ES2287634T3 (es) 2007-12-16
PL1574572T3 (pl) 2007-10-31
DE602004006599T2 (de) 2008-01-31
AU2005219815A1 (en) 2005-09-15
AU2005219815B2 (en) 2009-08-20
CA2559114A1 (en) 2005-09-15
US20090233981A1 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
DK1776460T3 (da) Fremgangsmåde til modulering af genekspression ved ændring af CpG-indholdet
DE50115863D1 (de) Verfahren zur regelung der fahrstabilität
WO2005065321A3 (en) Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids
DE60223299D1 (de) Verfahren zur Sequenzierung von Nukleinsäuren
WO2006083800A3 (en) Nucleic acid silencing of huntington's disease gene
WO2006029258A3 (en) Aptamer medicinal chemistry
WO2005030982A3 (en) Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs
EP2029721A4 (de) Gleichzeitige amplifikation und identifizierung von ribonukleinsäure mit einem optischen verfahren unter verwendung von plasmonresonanz
AU2003236637A8 (en) Universal rt-coupled pcr method for the specific amplification of mrna
DE602005009693D1 (de) 2"-nitrobenzyl-modifizierte ribonukleotide
EP2058396A4 (de) Nukleinsäureamplifikationsverfahren
DE60223704D1 (de) Vorrichtung zur extraktion von nukleinsäuren
EP1730309A4 (de) Zusammensetzungen und verfahren zur optimierung der spaltung von rna durch rnase h
DE602007011237D1 (de) Amplifikation von dna-fragmenten
WO2008083327A3 (en) Enrichment through heteroduplexed molecules
AU2003280603A8 (en) Method of amplifying nucleic acid
DE60300343D1 (de) Verfahren zur Berechnung des Motordrehmoments
DE602004023631D1 (de) Verfahren zur einführung einer nukleinsäure
DK1574572T3 (da) Forbindelser til hydrolyse af ribonukleinsyrer (RNA'er)
ITMI20031518A1 (it) Metodo di pilotaggio di moduli lcd a basso consumo
DE60228089D1 (de) Nukleinsäureamplifikation mit duplexzwischenprodukten
DE50204680D1 (de) Verfahren zur detektion von nukleinsäuremolekülen
DK1765770T3 (da) Fremgangsmåde til fremstilling af gabapentin
DE60138242D1 (de) Verfahren zur Quantifizierung von spezifischen Nukleinsäuren durch isomere Primerverlängerung
WO2007103767A3 (en) Role of microrna in plant salt tolerance